ALPHA TRIBE

Vijaya Diagnostic Centre LimitedPPTs, 12-05-2025: Investor Presentation

12-05-2025 | 03:08 pm

1. Financial Highlights:

Vijaya Diagnostic Centre posted revenue of ₹1,732 Mn in Q4 and ₹6,814 Mn for FY25, growing 24.4% YoY for the year. EBITDA margin held steady near 40%, with Q4 EBITDA at ₹689 Mn and ₹2,732 Mn for FY25. PAT came in at ₹346 Mn (20.0% margin) for Q4 and ₹1,431 Mn (21.0% margin) for the full year, showing solid profitability despite a minor margin dip. Footfalls totaled 4.19 Mn with 14.79 Mn tests done annually, yielding revenue per footfall around ₹1,627. The balance sheet remains strong with equity rising to ₹7,993 Mn and borrowings well controlled.

2. Strategic Initiatives & Growth Drivers:

Vijaya expanded aggressively, adding six new hubs across Pune, Bengaluru, and West Bengal, plus two spokes in Pune following the PH Diagnostic acquisition. Further openings are planned in West Bengal and Tier-2 cities in AP and Telangana to deepen market penetration. Investments include advanced diagnostic tech such as 3T MRI and CT scanners and AI-powered radiology software “Augmento,” enhancing turnaround times and report accuracy. The hub-and-spoke model underpins scalable geographic and operational growth.

3. Business Developments:

The PH Diagnostic Centre acquisition has been fully integrated since December 2023, boosting revenue and operations. Organic growth continued with new hubs launched in Ambegaon and Kalyani Nagar (Pune), HSR Layout and Yelahanka (Bengaluru), and Krishnanagar and Barasat (West Bengal). Emphasis on technology-led diagnostics supports efficiency and customer experience enhancements.

4. Market Position & Competitive Advantage:

As India’s largest integrated B2C diagnostic chain, Vijaya operates 151 centers in 25 cities, dominating Telangana and AP with over 90% B2C revenue share. Its hub-and-spoke network enables faster test turnaround and strong brand equity. Early adoption of AI in radiology and NABL-accredited labs bolster quality and reliability. Geographic diversity and an extensive service mix set it apart in a fragmented industry.

5. Investor Implications:

Robust double-digit growth, healthy margins, and expansion initiatives indicate promising growth potential. Acquisition synergies and new hubs support scaling, while ongoing tech adoption and brand strength may drive market share gains. Execution risks tied to rapid expansion and hub stabilization exist but operational momentum and margin stability appear sustainable.

No comments yet. Be the first to comment!

All announcements from Vijaya Diagnostic Centre Limited